Hearscape
Therapies database

Find a therapy. Follow the evidence.

See what is being studies, who is developing it, and how far it has progressed.

Search therapy records

Search a therapy, company, target, indication, or trial ID. Narrow by approach, stage, or status, then open a record to check its sources.

More filters and sort (1 active)
4 results
SPI-1005 by Sound Pharmaceuticals
Sound Pharmaceuticals · Small Molecule · Phase 3
ActiveTherapeuticStronger sources
Population
Adults · 18–75 years
Active Ménière’s disease
Evidence
trial
Confidence
90%
Indications
Hearing LossSensorineural Hearing LossNoise-Induced Hearing LossTinnitus
Details
AOK-1
Boehringer Ingelheim · Regenerative Medicine · Preclinical
ActiveTherapeuticStronger sources
Population
Adults · Not yet defined (preclinical)
Noise- or age-related cochlear hair-cell loss
Evidence
company
Confidence
82%
Indications
Hearing LossSensorineural Hearing LossAge-Related Hearing LossNoise-Induced Hearing Loss
Details
FX-322 by Frequency Therapeutics
Frequency Therapeutics · Regenerative Medicine · Phase 2
DiscontinuedTherapeutic
Population
Adults · 18–65 years
Stable noise- or sudden-onset SNHL
Evidence
company
Confidence
96%
Indications
Hearing LossSensorineural Hearing LossNoise-Induced Hearing LossSudden Sensorineural Hearing Loss
Details
NHPN-1010
Otologic Pharmaceutics · Small Molecule · Phase 1
CompletedTherapeutic
Population
Adults · 18–55 years
Hazardous noise or blast exposure
Evidence
company
Confidence
89%
Indications
Hearing LossSensorineural Hearing LossNoise-Induced Hearing LossTinnitus
Details

A listing is not proof of safety or effectiveness. Approval and availability may vary by indication and country.

How records are checked